Sort
17,828 grants matching “crispr”
Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies
$552,560Laurie T Krug · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
PNPLA3 in Susceptibility and Resistance to Fatty Liver Disease
$552,559Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2024 · DK
CRISPR editing therapy for Duchenne muscular dystrophy
$552,403Dongsheng Duan · University Of Missouri-Columbia · R01 · FY2024 · NS
Dissecting and targeting lysosomal signaling in kidney tumorigenesis
$552,374Roberto Zoncu · University Of California Berkeley · R01 · FY2022 · CA
Carbonic Anhydrase as a Cardioprotective Target in Anthracycline-induced Cardiotoxicity
$552,318Chun Liu · Medical College Of Wisconsin · R01 · FY2025 · HL
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$552,186Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2020 · CA
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$552,186Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2021 · CA
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$552,186Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2019 · CA
Mechanisms of epithelial repair and remodeling in pulmonary fibrosis
$552,067Jonathan Andrew Kropski · Vanderbilt University Medical Center · R01 · FY2021 · HL
Collaborative Research: Redirecting cellular metabolism via synthetic toehold-gated dCas9 regulators
$552,000Wilfred Chen · University Of Delaware · · FY2018 · BIO
Understanding the Molecular Genetic Mechanisms of Asthma Risk Loci: IL33, IL1RL1, and GSDMB
$551,981Erin D. Gordon · University Of California, San Francisco · R01 · FY2018 · AI
Molecular mechanisms of developmental reprogramming in colorectal cancer
$551,848Nilay Sethi · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Molecular mechanisms of developmental reprogramming in colorectal cancer
$551,848Nilay Sethi · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Development and characterization of mouse models of RP59 DHDDS deficiency
$551,693Steven J Pittler · University Of Alabama At Birmingham · R01 · FY2019 · EY
Computational and experimental methods for scalable identification of oncogenic non-coding regions
$551,605Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
The Investigation of disease causing genes in C. elegans
$551,605Andy Golden · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Cellular Determinants and Function Consequences of PP2A-B56 Degradation by HIV-1 Vif
$551,363Jeffrey R Johnson · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AI
Cellular Determinants and Function Consequences of PP2A-B56 Degradation by HIV-1 Vif
$551,363Jeffrey R Johnson · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI
Cellular Determinants and Function Consequences of PP2A-B56 Degradation by HIV-1 Vif
$551,363Jeffrey R Johnson · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
HSET as a racial disparity biomarker for TNBC patients
$551,345Ritu Aneja · University Of Alabama At Birmingham · R01 · FY2022 · CA
Connecting 3D genome misfolding to transcriptional silencing in fragile X syndrome
$551,288Jennifer Elizabeth Phillips-Cremins · University Of Pennsylvania · R01 · FY2020 · MH
Project 4: Transcriptional Coactivators and Enhancers in Human Cancer
$551,286Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2020 · CA
Project 4: Transcriptional Coactivators and Enhancers in Human Cancer
$551,286Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2021 · CA
Evaluating the Functional Impact of Genetic Diversity on Malaria Vaccine Candidates
$551,244Amy Kristine Bei · Yale University · R01 · FY2025 · AI
Study cell cycle regulation in dormant tumor cells
$551,209Steven Cappell · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA